Global Cell and Gene Therapy Manufacturing Quality Control Supply, Demand and Key Producers, 2023-2029

Global Cell and Gene Therapy Manufacturing Quality Control Supply, Demand and Key Producers, 2023-2029

The global Cell and Gene Therapy Manufacturing Quality Control market size is expected to reach $ 1325.4 million by 2029, rising at a market growth of 18.2% CAGR during the forecast period (2023-2029).

This report studies the global Cell and Gene Therapy Manufacturing Quality Control demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Manufacturing Quality Control, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Manufacturing Quality Control that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Cell and Gene Therapy Manufacturing Quality Control total market, 2018-2029, (USD Million)

Global Cell and Gene Therapy Manufacturing Quality Control total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Cell and Gene Therapy Manufacturing Quality Control total market, key domestic companies and share, (USD Million)

Global Cell and Gene Therapy Manufacturing Quality Control revenue by player and market share 2018-2023, (USD Million)

Global Cell and Gene Therapy Manufacturing Quality Control total market by Type, CAGR, 2018-2029, (USD Million)

Global Cell and Gene Therapy Manufacturing Quality Control total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Cell and Gene Therapy Manufacturing Quality Control market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories,Inc., QIAGEN, Charles River Laboratories International, Inc., Lonza Group AG, Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc. and Intertek Group Plc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Manufacturing Quality Control market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell and Gene Therapy Manufacturing Quality Control Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cell and Gene Therapy Manufacturing Quality Control Market, Segmentation by Type
Sterility Testing
Purity Testing
Potency Testing
Identity Testing
Others

Global Cell and Gene Therapy Manufacturing Quality Control Market, Segmentation by Application
Pharmaceutical & Biotechnology Companies
Contract Manufacturing Organizations

Companies Profiled:
Bio-Rad Laboratories,Inc.
QIAGEN
Charles River Laboratories International, Inc.
Lonza Group AG
Bio-Techne Corporation
Merck KGaA
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific, Inc.
Intertek Group Plc
Eurofins Scientific S.E.

Key Questions Answered

1. How big is the global Cell and Gene Therapy Manufacturing Quality Control market?

2. What is the demand of the global Cell and Gene Therapy Manufacturing Quality Control market?

3. What is the year over year growth of the global Cell and Gene Therapy Manufacturing Quality Control market?

4. What is the total value of the global Cell and Gene Therapy Manufacturing Quality Control market?

5. Who are the major players in the global Cell and Gene Therapy Manufacturing Quality Control market?